re: 'Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications'' (vol 71, pg 55, 2017)

Gershman Boris; Van Houten Holly K.; Herrin Jeph; Moreira Daniel M.; Kim Simon P.; Shah Nilay D.; Karnes R. Jeffrey

首页> 外文期刊>European urology >re: 'Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications'' (vol 71, pg 55, 2017)

【24h】

re: 'Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications'' (vol 71, pg 55, 2017)

机译：Re：“前列腺特异性抗原（PSA）筛选试验和修订的PSA筛查指南对前列腺活组织检查和后期复杂性（第71号，PG 55,2017）的筛选指南

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2017年第5期|共1页
作者
Gershman Boris; Van Houten Holly K.; Herrin Jeph; Moreira Daniel M.; Kim Simon P.; Shah Nilay D.; Karnes R. Jeffrey;
展开▼
作者单位

Rhode Isl Hosp Div Urol Providence RI USA;

Mayo Clin Robert D &

Patricia E Kern Ctr Sci Healthcare Del Rochester MN USA;

Yale Univ Sch Med Div Cardiol New Haven CT USA;

Univ Illinois Dept Urol Chicago IL USA;

Case Western Reserve Univ Sch Med Dept Urol Univ Hosp Case Med Ctr Urol Inst Cleveland OH USA;

Mayo Clin Robert D &

Patricia E Kern Ctr Sci Healthcare Del Rochester MN USA;

Mayo Clin Dept Urol 200 First St SW Rochester MN 55905 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. re: "Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications'' (vol 71, pg 55, 2017) [J] . Gershman Boris, Van Houten Holly K., Herrin Jeph, European urology . 2017,第5期

机译：Re：“前列腺特异性抗原（PSA）筛选试验和修订的PSA筛查指南对前列腺活组织检查和后期复杂性（第71号，PG 55,2017）的筛选指南
2. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume [J] . CorcoranN.M., CaseyR.G., HongM.K.H., BJU international . 2012,第1期

机译：由于每单位肿瘤体积PSA分泌减少，前列腺特异性抗原（PSA）密度预测初始前列腺活检和前列腺切除术之间的Gleason评分升级的能力随肿瘤等级的增加而降低
3. Prostate-specific antigen (PSA) screening rates and factors associated with screening in Eastern Canadian men: Findings from cross-sectional survey data [J] . Devan Tchir, Marwa Farag, Michael Szafron Canadian Urological Association Journal . 2020,第7期

机译：特异性抗原（PSA）筛选率和与东部的筛选相关的因素：来自横断面调查数据的结果
4. Detection of Prostate-Specific Antigen (PSA) with an Ultra High Performance Electrode Modified with Sol-gel Au Nanoparticles [C] . Solomon W. Leung, Seyedeh M. Mozneb, James C. K. Lai, Annual NSTI nanotechnology conference and expo;TechConnect world innovation conference expo . 2014

机译：Sol-gel Au纳米粒子修饰的超高性能电极检测前列腺特异性抗原（PSA）
5. Risk-Based Simulation Optimization of PSA-Based Prostate Cancer Screening. [D] . Underwood, Daniel Jacob. 2015

机译：基于PSA的前列腺癌筛查的基于风险的仿真优化。
6. Updated results from the European Randomized Study of Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: are Asian countries encouraged to promote PSA screening? [O] . Mikio Sugimoto, Yoshiyuki Kakehi 2012

机译：欧洲对前列腺癌进行前列腺特异性抗原（PSA）筛查的随机研究的最新结果：是否鼓励亚洲国家促进PSA筛查？
7. PD30-01 PROSTATE-SPECIFIC ANTIGEN (PSA) LEVELS IN MEN 60 TO 70 YEARS OF AGE PREDICT AGGRESSIVE PROSTATE CANCER IN THE PLCO CANCER SCREENING TRIAL: IMPLICATIONS FOR RISK-STRATIFIED SCREENING [O] . Alexandra Berger*, Garrick Aden-Buie, Adam Kibel, 2019

机译：PD30-01前列腺特异性抗原（PSA）60至70岁的男性水平预测PLCO癌症筛查试验中的侵袭性前列腺癌：对风险分层筛查的影响

re: 'Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications'' (vol 71, pg 55, 2017)

著录项

相似文献

相关主题

期刊订阅